Role of glycated hemoglobin in the screening and diagnosis of posttransplantation diabetes mellitus after renal transplantation: A diagnostic accuracy study

The role of glycated hemoglobin (A1C) in the screening and diagnosis of posttransplantation diabetes mellitus (PTDM) is still not entirely understood. We evaluated the use of A1C test in renal transplant recipients at four months after transplantation. A total of 122 out of 274 patients without prev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2015-05, Vol.445, p.48-53
Hauptverfasser: Pimentel, Ana Laura, Carvalho, Larissa Sant Anna Kellermann, Marques, Samara Silva, Franco, Rodrigo Fontanive, Silveiro, Sandra Pinho, Manfro, Roberto Ceratti, Camargo, Joíza Lins
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 53
container_issue
container_start_page 48
container_title Clinica chimica acta
container_volume 445
creator Pimentel, Ana Laura
Carvalho, Larissa Sant Anna Kellermann
Marques, Samara Silva
Franco, Rodrigo Fontanive
Silveiro, Sandra Pinho
Manfro, Roberto Ceratti
Camargo, Joíza Lins
description The role of glycated hemoglobin (A1C) in the screening and diagnosis of posttransplantation diabetes mellitus (PTDM) is still not entirely understood. We evaluated the use of A1C test in renal transplant recipients at four months after transplantation. A total of 122 out of 274 patients without previous diabetes that underwent kidney transplantation were enrolled. ROC curve was used to analyze the performance of A1C to diagnose PTDM considering OGTT as the reference standard. OGTT identified 32 (26.2%) patients with PTDM, whereas A1C≥6.5% (48mmol/mol) identified only 16 patients. A1C showed moderate accuracy to detect PTDM in the ROC curve [AUC 0.832 (95% CI 0.740–0.924, p
doi_str_mv 10.1016/j.cca.2015.03.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1676341199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009898115001485</els_id><sourcerecordid>1676341199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-4f85ae257b6c443366f2c6bae7a62207aa6c1aff15ac2f8235d41733a6903d213</originalsourceid><addsrcrecordid>eNp9kcFq3DAQhkVpaTZpH6CXomMvdiXLlu32FELaFAKB0p7FWBpttNjSVpID-y552GjZpIceCgPDDN__M8NPyAfOas64_LyrtYa6YbyrmajL5hXZ8KEXlWjH5jXZMMbGahgHfkbOU9qVsWWSvyVnTdeP_TDKDXn8GWakwdLtfNCQ0dB7XMJ2DpPztFS-R5p0RPTObyl4Q42DrQ_JpaNqH1LOEXzaz-AzZBf8EZgwY6ILzrPLa6JgM0Ya0cNM_6G_0MsXx-w0Ba3XCPpAU17N4R15Y2FO-P65X5Df365_Xd1Ut3fff1xd3lZadCJXrR06wPLTJHXbCiGlbbScAHuQTcN6AKk5WMs70I0dGtGZlvdCgByZMA0XF-TTyXcfw58VU1aLS7pcDx7DmhSXvRQt5-NYUH5CdQwpRbRqH90C8aA4U8dQ1E6VUNQxFMWEKpui-fhsv04Lmr-KlxQK8PUEYHnywWFUSTv0Go2LqLMywf3H_gk8r6Ct</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1676341199</pqid></control><display><type>article</type><title>Role of glycated hemoglobin in the screening and diagnosis of posttransplantation diabetes mellitus after renal transplantation: A diagnostic accuracy study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Pimentel, Ana Laura ; Carvalho, Larissa Sant Anna Kellermann ; Marques, Samara Silva ; Franco, Rodrigo Fontanive ; Silveiro, Sandra Pinho ; Manfro, Roberto Ceratti ; Camargo, Joíza Lins</creator><creatorcontrib>Pimentel, Ana Laura ; Carvalho, Larissa Sant Anna Kellermann ; Marques, Samara Silva ; Franco, Rodrigo Fontanive ; Silveiro, Sandra Pinho ; Manfro, Roberto Ceratti ; Camargo, Joíza Lins</creatorcontrib><description>The role of glycated hemoglobin (A1C) in the screening and diagnosis of posttransplantation diabetes mellitus (PTDM) is still not entirely understood. We evaluated the use of A1C test in renal transplant recipients at four months after transplantation. A total of 122 out of 274 patients without previous diabetes that underwent kidney transplantation were enrolled. ROC curve was used to analyze the performance of A1C to diagnose PTDM considering OGTT as the reference standard. OGTT identified 32 (26.2%) patients with PTDM, whereas A1C≥6.5% (48mmol/mol) identified only 16 patients. A1C showed moderate accuracy to detect PTDM in the ROC curve [AUC 0.832 (95% CI 0.740–0.924, p&lt;0.001)]. A1C of 5.8% (40mmol/mol) was the equilibrium point (sensitivity 75% and specificity 72.2%) and A1C≥6.2% (44mmol/mol) showed high specificity of 93.3%. A1C≥6.5% (48mmol/mol) is not enough to be used alone in the diagnosis of PTDM. The combined use of A1C cut-off points of ≤5.8% (40mmol/mol) and ≥6.2% (44mmol/mol) would reduce the number of OGTT by 85%. The use of an algorithm with A1C test in combination with FPG and/or 2h-PG proved to be the most efficient strategy to diagnose or rule out PTDM. •The performance of A1c to detect PTDM was evaluated in 122 patients that underwent kidney transplantation.•A1c ≥6.5% (48mmol/mol) is not enough to be used alone in the diagnosis of PTDM.•A1c ≤5.8% (40mmol/mol) presented adequate sensitivity to rule out PTDM.•A1c ≥6.2% (44mmol/mol) showed excellent specificity to rule in PTDM.•A1c test in combination with OGTT proved to be the most efficient alternative strategy to exclude or confirm PTDM.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/j.cca.2015.03.016</identifier><identifier>PMID: 25797896</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>A1C ; Adult ; Aged ; Biomarkers - blood ; Blood Glucose - metabolism ; Cross-Sectional Studies ; Diabetes Mellitus - blood ; Diabetes Mellitus - diagnosis ; Diabetes Mellitus - etiology ; Diabetes Mellitus - pathology ; Diagnostic accuracy ; Female ; Glucose Tolerance Test ; Glycated hemoglobin ; Glycated Hemoglobin A - metabolism ; Humans ; Kidney - metabolism ; Kidney - pathology ; Kidney Transplantation - adverse effects ; Male ; Middle Aged ; Posttransplantation diabetes mellitus ; PTDM ; Renal transplantation ; ROC Curve</subject><ispartof>Clinica chimica acta, 2015-05, Vol.445, p.48-53</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-4f85ae257b6c443366f2c6bae7a62207aa6c1aff15ac2f8235d41733a6903d213</citedby><cites>FETCH-LOGICAL-c353t-4f85ae257b6c443366f2c6bae7a62207aa6c1aff15ac2f8235d41733a6903d213</cites><orcidid>0000-0003-3163-2097</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cca.2015.03.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25797896$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pimentel, Ana Laura</creatorcontrib><creatorcontrib>Carvalho, Larissa Sant Anna Kellermann</creatorcontrib><creatorcontrib>Marques, Samara Silva</creatorcontrib><creatorcontrib>Franco, Rodrigo Fontanive</creatorcontrib><creatorcontrib>Silveiro, Sandra Pinho</creatorcontrib><creatorcontrib>Manfro, Roberto Ceratti</creatorcontrib><creatorcontrib>Camargo, Joíza Lins</creatorcontrib><title>Role of glycated hemoglobin in the screening and diagnosis of posttransplantation diabetes mellitus after renal transplantation: A diagnostic accuracy study</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>The role of glycated hemoglobin (A1C) in the screening and diagnosis of posttransplantation diabetes mellitus (PTDM) is still not entirely understood. We evaluated the use of A1C test in renal transplant recipients at four months after transplantation. A total of 122 out of 274 patients without previous diabetes that underwent kidney transplantation were enrolled. ROC curve was used to analyze the performance of A1C to diagnose PTDM considering OGTT as the reference standard. OGTT identified 32 (26.2%) patients with PTDM, whereas A1C≥6.5% (48mmol/mol) identified only 16 patients. A1C showed moderate accuracy to detect PTDM in the ROC curve [AUC 0.832 (95% CI 0.740–0.924, p&lt;0.001)]. A1C of 5.8% (40mmol/mol) was the equilibrium point (sensitivity 75% and specificity 72.2%) and A1C≥6.2% (44mmol/mol) showed high specificity of 93.3%. A1C≥6.5% (48mmol/mol) is not enough to be used alone in the diagnosis of PTDM. The combined use of A1C cut-off points of ≤5.8% (40mmol/mol) and ≥6.2% (44mmol/mol) would reduce the number of OGTT by 85%. The use of an algorithm with A1C test in combination with FPG and/or 2h-PG proved to be the most efficient strategy to diagnose or rule out PTDM. •The performance of A1c to detect PTDM was evaluated in 122 patients that underwent kidney transplantation.•A1c ≥6.5% (48mmol/mol) is not enough to be used alone in the diagnosis of PTDM.•A1c ≤5.8% (40mmol/mol) presented adequate sensitivity to rule out PTDM.•A1c ≥6.2% (44mmol/mol) showed excellent specificity to rule in PTDM.•A1c test in combination with OGTT proved to be the most efficient alternative strategy to exclude or confirm PTDM.</description><subject>A1C</subject><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Blood Glucose - metabolism</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes Mellitus - diagnosis</subject><subject>Diabetes Mellitus - etiology</subject><subject>Diabetes Mellitus - pathology</subject><subject>Diagnostic accuracy</subject><subject>Female</subject><subject>Glucose Tolerance Test</subject><subject>Glycated hemoglobin</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Kidney - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Posttransplantation diabetes mellitus</subject><subject>PTDM</subject><subject>Renal transplantation</subject><subject>ROC Curve</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFq3DAQhkVpaTZpH6CXomMvdiXLlu32FELaFAKB0p7FWBpttNjSVpID-y552GjZpIceCgPDDN__M8NPyAfOas64_LyrtYa6YbyrmajL5hXZ8KEXlWjH5jXZMMbGahgHfkbOU9qVsWWSvyVnTdeP_TDKDXn8GWakwdLtfNCQ0dB7XMJ2DpPztFS-R5p0RPTObyl4Q42DrQ_JpaNqH1LOEXzaz-AzZBf8EZgwY6ILzrPLa6JgM0Ya0cNM_6G_0MsXx-w0Ba3XCPpAU17N4R15Y2FO-P65X5Df365_Xd1Ut3fff1xd3lZadCJXrR06wPLTJHXbCiGlbbScAHuQTcN6AKk5WMs70I0dGtGZlvdCgByZMA0XF-TTyXcfw58VU1aLS7pcDx7DmhSXvRQt5-NYUH5CdQwpRbRqH90C8aA4U8dQ1E6VUNQxFMWEKpui-fhsv04Lmr-KlxQK8PUEYHnywWFUSTv0Go2LqLMywf3H_gk8r6Ct</recordid><startdate>20150520</startdate><enddate>20150520</enddate><creator>Pimentel, Ana Laura</creator><creator>Carvalho, Larissa Sant Anna Kellermann</creator><creator>Marques, Samara Silva</creator><creator>Franco, Rodrigo Fontanive</creator><creator>Silveiro, Sandra Pinho</creator><creator>Manfro, Roberto Ceratti</creator><creator>Camargo, Joíza Lins</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3163-2097</orcidid></search><sort><creationdate>20150520</creationdate><title>Role of glycated hemoglobin in the screening and diagnosis of posttransplantation diabetes mellitus after renal transplantation: A diagnostic accuracy study</title><author>Pimentel, Ana Laura ; Carvalho, Larissa Sant Anna Kellermann ; Marques, Samara Silva ; Franco, Rodrigo Fontanive ; Silveiro, Sandra Pinho ; Manfro, Roberto Ceratti ; Camargo, Joíza Lins</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-4f85ae257b6c443366f2c6bae7a62207aa6c1aff15ac2f8235d41733a6903d213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>A1C</topic><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Blood Glucose - metabolism</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes Mellitus - diagnosis</topic><topic>Diabetes Mellitus - etiology</topic><topic>Diabetes Mellitus - pathology</topic><topic>Diagnostic accuracy</topic><topic>Female</topic><topic>Glucose Tolerance Test</topic><topic>Glycated hemoglobin</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Kidney - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Posttransplantation diabetes mellitus</topic><topic>PTDM</topic><topic>Renal transplantation</topic><topic>ROC Curve</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pimentel, Ana Laura</creatorcontrib><creatorcontrib>Carvalho, Larissa Sant Anna Kellermann</creatorcontrib><creatorcontrib>Marques, Samara Silva</creatorcontrib><creatorcontrib>Franco, Rodrigo Fontanive</creatorcontrib><creatorcontrib>Silveiro, Sandra Pinho</creatorcontrib><creatorcontrib>Manfro, Roberto Ceratti</creatorcontrib><creatorcontrib>Camargo, Joíza Lins</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pimentel, Ana Laura</au><au>Carvalho, Larissa Sant Anna Kellermann</au><au>Marques, Samara Silva</au><au>Franco, Rodrigo Fontanive</au><au>Silveiro, Sandra Pinho</au><au>Manfro, Roberto Ceratti</au><au>Camargo, Joíza Lins</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of glycated hemoglobin in the screening and diagnosis of posttransplantation diabetes mellitus after renal transplantation: A diagnostic accuracy study</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>2015-05-20</date><risdate>2015</risdate><volume>445</volume><spage>48</spage><epage>53</epage><pages>48-53</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>The role of glycated hemoglobin (A1C) in the screening and diagnosis of posttransplantation diabetes mellitus (PTDM) is still not entirely understood. We evaluated the use of A1C test in renal transplant recipients at four months after transplantation. A total of 122 out of 274 patients without previous diabetes that underwent kidney transplantation were enrolled. ROC curve was used to analyze the performance of A1C to diagnose PTDM considering OGTT as the reference standard. OGTT identified 32 (26.2%) patients with PTDM, whereas A1C≥6.5% (48mmol/mol) identified only 16 patients. A1C showed moderate accuracy to detect PTDM in the ROC curve [AUC 0.832 (95% CI 0.740–0.924, p&lt;0.001)]. A1C of 5.8% (40mmol/mol) was the equilibrium point (sensitivity 75% and specificity 72.2%) and A1C≥6.2% (44mmol/mol) showed high specificity of 93.3%. A1C≥6.5% (48mmol/mol) is not enough to be used alone in the diagnosis of PTDM. The combined use of A1C cut-off points of ≤5.8% (40mmol/mol) and ≥6.2% (44mmol/mol) would reduce the number of OGTT by 85%. The use of an algorithm with A1C test in combination with FPG and/or 2h-PG proved to be the most efficient strategy to diagnose or rule out PTDM. •The performance of A1c to detect PTDM was evaluated in 122 patients that underwent kidney transplantation.•A1c ≥6.5% (48mmol/mol) is not enough to be used alone in the diagnosis of PTDM.•A1c ≤5.8% (40mmol/mol) presented adequate sensitivity to rule out PTDM.•A1c ≥6.2% (44mmol/mol) showed excellent specificity to rule in PTDM.•A1c test in combination with OGTT proved to be the most efficient alternative strategy to exclude or confirm PTDM.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25797896</pmid><doi>10.1016/j.cca.2015.03.016</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3163-2097</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0009-8981
ispartof Clinica chimica acta, 2015-05, Vol.445, p.48-53
issn 0009-8981
1873-3492
language eng
recordid cdi_proquest_miscellaneous_1676341199
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects A1C
Adult
Aged
Biomarkers - blood
Blood Glucose - metabolism
Cross-Sectional Studies
Diabetes Mellitus - blood
Diabetes Mellitus - diagnosis
Diabetes Mellitus - etiology
Diabetes Mellitus - pathology
Diagnostic accuracy
Female
Glucose Tolerance Test
Glycated hemoglobin
Glycated Hemoglobin A - metabolism
Humans
Kidney - metabolism
Kidney - pathology
Kidney Transplantation - adverse effects
Male
Middle Aged
Posttransplantation diabetes mellitus
PTDM
Renal transplantation
ROC Curve
title Role of glycated hemoglobin in the screening and diagnosis of posttransplantation diabetes mellitus after renal transplantation: A diagnostic accuracy study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A41%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20glycated%20hemoglobin%20in%20the%20screening%20and%20diagnosis%20of%20posttransplantation%20diabetes%20mellitus%20after%20renal%20transplantation:%20A%20diagnostic%20accuracy%20study&rft.jtitle=Clinica%20chimica%20acta&rft.au=Pimentel,%20Ana%20Laura&rft.date=2015-05-20&rft.volume=445&rft.spage=48&rft.epage=53&rft.pages=48-53&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/j.cca.2015.03.016&rft_dat=%3Cproquest_cross%3E1676341199%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1676341199&rft_id=info:pmid/25797896&rft_els_id=S0009898115001485&rfr_iscdi=true